Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
HumanPheno	Square-wave jerks	SYNE1 VPS13A	2.42e-05	3	15	2	HP:0025402
HumanPheno	Saccadic intrusion	SYNE1 VPS13A	2.42e-05	3	15	2	HP:0032114
Domain	HEMATOPO_REC_S_F1	CRLF2 IL7R	2.36e-04	8	55	2	PS01355
Domain	Hempt_rcpt_S_F1_CS	CRLF2 IL7R	3.02e-04	9	55	2	IPR003531
Domain	Synaptotagmin	SYT6 SYT9	1.56e-03	20	55	2	IPR001565
Domain	FN3	PTPRK FNDC3A CRLF2 IL7R	2.79e-03	199	55	4	PS50853
Domain	FN3_dom	PTPRK FNDC3A CRLF2 IL7R	3.33e-03	209	55	4	IPR003961
Domain	SNF2_N	EP400 INO80	3.99e-03	32	55	2	PF00176
Domain	SNF2_N	EP400 INO80	3.99e-03	32	55	2	IPR000330
Domain	fn3	PTPRK FNDC3A IL7R	1.21e-02	162	55	3	PF00041
Pubmed	IL-7Rα Expression Regulates Murine Dendritic Cell Sensitivity to Thymic Stromal Lymphopoietin.	CRLF2 IL7R	2.64e-06	2	57	2	28404633
Pubmed	Novel activating mutations lacking cysteine in type I cytokine receptors in acute lymphoblastic leukemia.	CRLF2 IL7R	2.64e-06	2	57	2	24787007
Pubmed	Whole-genome profiling of DNA methylation and hydroxymethylation identifies distinct regulatory programs among innate lymphocytes.	TET2 IL7R	2.64e-06	2	57	2	35332328
Pubmed	Identification of amino acids in transmembrane domains of mutated cytokine receptor-like factor 2 and interleukin-7 receptor α required for constitutive signal transduction.	CRLF2 IL7R	2.64e-06	2	57	2	38862034
Pubmed	Novel function for interleukin-7 in dendritic cell development.	CRLF2 IL7R	7.91e-06	3	57	2	19246338
Pubmed	TSLP and TSLP receptors variants are associated with smoking.	CRLF2 IL7R	7.91e-06	3	57	2	31290290
Pubmed	The survival and differentiation of pro-B and pre-B cells in the bone marrow is dependent on IL-7Rα Tyr449.	CRLF2 IL7R	7.91e-06	3	57	2	25143441
Pubmed	Upregulated thymic stromal lymphopoietin receptor expression in children with asthma.	CRLF2 IL7R	7.91e-06	3	57	2	26999524
Pubmed	Expression and Polymorphism of TSLP/TSLP Receptors as Potential Diagnostic Markers of Colorectal Cancer Progression.	CRLF2 IL7R	7.91e-06	3	57	2	34573368
Pubmed	Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum.	CRLF2 IL7R	7.91e-06	3	57	2	20466416
Pubmed	DOT1L activity affects neural stem cell division mode and reduces differentiation and ASNS expression.	BTG2 DOT1L	7.91e-06	3	57	2	37382163
Pubmed	Unusual timing of CD127 expression by mouse uterine natural killer cells.	CRLF2 IL7R	1.58e-05	4	57	2	22227963
Pubmed	The development and survival but not function of follicular B cells is dependent on IL-7Rα Tyr449 signaling.	CRLF2 IL7R	1.58e-05	4	57	2	24551160
Pubmed	Permissive roles of hematopoietin and cytokine tyrosine kinase receptors in early T-cell development.	CRLF2 IL7R	1.58e-05	4	57	2	18039955
Pubmed	Interleukin-7, but not thymic stromal lymphopoietin, plays a key role in the T cell response to influenza A virus.	CRLF2 IL7R	2.63e-05	5	57	2	23189186
Pubmed	FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesis.	CRLF2 IL7R	2.63e-05	5	57	2	18566323
Pubmed	IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages.	CRLF2 IL7R	2.63e-05	5	57	2	23530149
Pubmed	Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.	CRLF2 IL7R	2.63e-05	5	57	2	18664628
Pubmed	Human thymic stromal lymphopoietin preferentially stimulates myeloid cells.	CRLF2 IL7R	3.94e-05	6	57	2	11418668
Pubmed	Identification of synaptotagmin effectors via acute inhibition of secretion from cracked PC12 cells.	SYT6 SYT9	3.94e-05	6	57	2	12860971
Pubmed	Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin.	CRLF2 IL7R	3.94e-05	6	57	2	20174635
Pubmed	Adaptive endoplasmic reticulum stress signalling via IRE1α-XBP1 preserves self-renewal of haematopoietic and pre-leukaemic stem cells.	TET2 ERN1	5.51e-05	7	57	2	30778220
Pubmed	Expert curation of the human and mouse olfactory receptor gene repertoires identifies conserved coding regions split across two exons.	OR5H15 OR5H14 OR5H1	6.03e-05	46	57	3	32126975
Pubmed	The single-cell transcriptional landscape of mammalian organogenesis.	ADAMTS3 FNDC3A	7.34e-05	8	57	2	30787437
Pubmed	Conserved N-terminal cysteine motif is essential for homo- and heterodimer formation of synaptotagmins III, V, VI, and X.	SYT6 SYT9	9.43e-05	9	57	2	10531343
Pubmed	Mechanical Skin Injury Promotes Food Anaphylaxis by Driving Intestinal Mast Cell Expansion.	CRLF2 IL7R	9.43e-05	9	57	2	31027995
Pubmed	Mirror image motifs mediate the interaction of the COOH terminus of multiple synaptotagmins with the neurexins and calmodulin.	SYT6 SYT9	9.43e-05	9	57	2	8901523
Pubmed	Distinct developmental expression of synaptotagmin I and IX in the mouse brain.	SYT6 SYT9	9.43e-05	9	57	2	16407767
Pubmed	The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells.	CRLF2 IL7R	9.43e-05	9	57	2	23063333
Pubmed	Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.	CRLF2 IL7R	1.18e-04	10	57	2	20974963
Pubmed	Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit.	CRLF2 IL7R	1.44e-04	11	57	2	26675736
Pubmed	Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes.	CRLF2 IL7R	1.44e-04	11	57	2	21093318
Pubmed	IL-7Rα glutamylation and activation of transcription factor Sall3 promote group 3 ILC development.	TTLL6 IL7R	1.72e-04	12	57	2	28794449
Pubmed	Genomic analysis of synaptotagmin genes.	SYT6 SYT9	2.03e-04	13	57	2	11543631
Pubmed	Defining brain wiring patterns and mechanisms through gene trapping in mice.	PTPRK IL17RD	2.37e-04	14	57	2	11242070
Pubmed	A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease.	PTPRK TADA3 PLEKHM1	2.59e-04	75	57	3	15383276
Pubmed	Identification and proteomic profiling of exosomes in human urine.	TSG101 CA4	5.43e-04	21	57	2	15326289
Pubmed	Replication of a genome-wide case-control study of esophageal squamous cell carcinoma.	SYNE1 EPG5	9.02e-04	27	57	2	18649358
Pubmed	Modulation of the combinatorial code of odorant receptor response patterns in odorant mixtures.	OR5AC1 OR5H1	9.02e-04	27	57	2	32061665
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	TET2 EP400 CLSTN1	1.29e-03	130	57	3	12421765
Pubmed	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	STK11 ABCA12 SYT9	1.41e-03	134	57	3	24324551
Cytoband	Ensembl 112 genes in cytogenetic band chr3q11	OR5AC1 OR5H15 OR5H14 OR5H1	6.45e-07	54	57	4	chr3q11
Cytoband	3q12.1	OR5H15 OR5H14	3.13e-04	21	57	2	3q12.1
Cytoband	3q11.2	OR5AC1 OR5H1	4.83e-04	26	57	2	3q11.2
Cytoband	11q23.3	HINFP SC5D	4.28e-03	78	57	2	11q23.3
GeneFamily	Olfactory receptors, family 5	OR5AC1 OR5H15 OR5H14 OR5H1	1.18e-04	112	41	4	152
GeneFamily	Fibronectin type III domain containing	PTPRK FNDC3A CRLF2 IL7R	4.64e-04	160	41	4	555
GeneFamily	Synaptotagmins	SYT6 SYT9	6.68e-04	17	41	2	765
GeneFamily	CD molecules\|I-set domain containing\|Immunoglobulin like domain containing\|Interleukin receptors\|TIR domain containing	IL17RD IL7R	4.08e-03	42	41	2	602
ToppCell	Leuk-UTI-Lymphocyte-T_NK-MAIT\|Leuk-UTI / Disease, Lineage and Cell Type	GALNT15 ERN1 SYNE1 IL7R	4.41e-05	153	57	4	ac3a1d1b5bf6009df818fd757dad7382d95c60dc
ToppCell	3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-MAIT\|Lung / Manually curated celltypes from each tissue	INTS6 BTG2 ERN1 IL7R	4.64e-05	155	57	4	72c61be0a8d3ee10600a33c58fb01c35fd3f14d4
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-LTi-like_NCR-_ILC3\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	INTS6 BTG2 ERN1 IL7R	6.06e-05	166	57	4	9fae71b0a42a9b2222453c03e0a1e83f30117ae9
ToppCell	3'_v3-Lung-Lymphocytic_Invariant-Inducer-like\|Lung / Manually curated celltypes from each tissue	INTS6 BTG2 ERN1 IL7R	6.35e-05	168	57	4	b9bde6f542d730682d34a80e1f7f1609e5c699c7
ToppCell	3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like\|bone_marrow / Manually curated celltypes from each tissue	INTS6 BTG2 ERN1 IL7R	6.80e-05	171	57	4	2977cffc146470733b5cfd8a1aa80d9346d4804d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT\|lymph-node_spleen / Manually curated celltypes from each tissue	INTS6 BTG2 ERN1 IL7R	7.60e-05	176	57	4	25c197d3b39deffa4801a1d12cdb54320cbae509
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PTPRK ADAMTS3 MAPK4 CA4	7.60e-05	176	57	4	212e643c50c68462d4b016428ab30eeb7868ef40
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ENPP6 TTLL6 ETNK2 SPDYE3	7.77e-05	177	57	4	ac90e4ce5be304a5a7473736397327010f2d1999
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PTPRK ADAMTS3 VILL IL7R	7.94e-05	178	57	4	b169aa5eaa51730daaec69c6bc58126be1592a50
ToppCell	3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT\|bone_marrow / Manually curated celltypes from each tissue	INTS6 BTG2 ERN1 IL7R	7.94e-05	178	57	4	7ac71e245864be2e8daecf555ff68235bd05827c
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ENPP6 CYP3A7 ADAMTS3 TDO2	8.29e-05	180	57	4	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like\|lymph-node_spleen / Manually curated celltypes from each tissue	INTS6 BTG2 ERN1 IL7R	9.03e-05	184	57	4	d97471a4fe17cba6880ccf1a04cc00c741558124
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17\|lymph-node_spleen / Manually curated celltypes from each tissue	INTS6 BTG2 ERN1 IL7R	9.81e-05	188	57	4	a20521198c6db17589535fb439533329582c9dd2
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	PTPRK SYNE1 IL7R CA4	1.02e-04	190	57	4	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ERN1 SYNE1 VPS13A IL7R	1.04e-04	191	57	4	4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	INTS6 ERN1 ETNK2 IL7R	1.06e-04	192	57	4	892789bdba150ef9a8a0012de52545f2ff6a31f6
ToppCell	COVID-19_Mild-Lymphoid_T/NK-MAIT\|COVID-19_Mild / Disease group, lineage and cell class	INTS6 ERN1 ETNK2 IL7R	1.06e-04	192	57	4	d47bd132e57f5b4bddcf3dfa399cee149eca7e44
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	INTS6 ERN1 ETNK2 IL7R	1.06e-04	192	57	4	24ea8fdcca2695aeb2e4b88161184124b7d332c1
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	INTS6 BTG2 ERN1 IL7R	1.06e-04	192	57	4	9a2560921b8c0997e1788053004f099439e8f071
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	INTS6 ERN1 ETNK2 IL7R	1.06e-04	192	57	4	44f440ee3842fe14665c4cd4f2aa48e7a5bbd9a8
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	INTS6 ERN1 ETNK2 IL7R	1.06e-04	192	57	4	8d50ad8cfe3cb9f183188b08457756af0ce56ffe
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	INTS6 BTG2 ERN1 IL7R	1.13e-04	195	57	4	d70b49f6b9c6c4422adb2936c837a1af7569fb0a
ToppCell	mild_COVID-19-MAIT\|mild_COVID-19 / disease group, cell group and cell class (v2)	INTS6 ERN1 ETNK2 IL7R	1.13e-04	195	57	4	b99815ec94042da1a2574468331b043d29d70b38
ToppCell	mLN-T_cell-Th17\|T_cell / Region, Cell class and subclass	INTS6 GCNT3 ERN1 IL7R	1.20e-04	198	57	4	efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2
ToppCell	tumor_Lung-Endothelial_cells-Tip-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	PTPRK TAX1BP1 IL7R CA4	1.22e-04	199	57	4	80c8641cfd84436eadf2234f1313749e2f73331f
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ENPP6 ADAMTS3 SYNE1 TDO2	1.24e-04	200	57	4	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	GCNT3 VILL TTLL6 SYT6	1.24e-04	200	57	4	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ENPP6 ADAMTS3 SYNE1 TDO2	1.24e-04	200	57	4	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-MAIT\|COVID-19_Mild / Disease, condition lineage and cell class	INTS6 ERN1 ETNK2 IL7R	1.24e-04	200	57	4	45b2a84d5a325f551205ae31c164d2de7773d3b6
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	GCNT3 VILL TTLL6 SYT6	1.24e-04	200	57	4	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-MAIT\|Leuk-UTI / Disease, condition lineage and cell class	ERN1 SYNE1 SPDYE3 IL7R	1.24e-04	200	57	4	7e0d0f051c197c2c70080f039e1c4dd68db8e74f
ToppCell	control-gd_T\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	INTS6 BTG2 SYNE1 IL7R	1.24e-04	200	57	4	b188f2acb9bd4f5f1ad4c3d3ddb9a55854a8b74b
Drug	thiophenone	SYNE1 TDO2	5.94e-06	2	56	2	CID009548690
Disease	blood pressure, response to thiazide, response to beta blocker	OR5H14 OR5H1	9.85e-06	3	54	2	EFO_0004325, EFO_0007766, EFO_0007981
Disease	prostate carcinoma, breast carcinoma, ovarian carcinoma	TET2 ARHGEF5	1.12e-03	27	54	2	EFO_0000305, EFO_0001075, EFO_0001663
Disease	upper respiratory tract disorder	TET2 IL7R	1.21e-03	28	54	2	MONDO_0004867
Disease	Antihypertensive use measurement	SYT6 PDP2 INO80 MAPK4	1.41e-03	265	54	4	EFO_0009927
Disease	Colorectal Carcinoma	TET2 STK11 ABCA12 SYNE1 VPS13A SYT9	1.74e-03	702	54	6	C0009402
Disease	ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis	STK11 ERN1 PTPRK FNDC3A	2.09e-03	295	54	4	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268
Disease	primary immunodeficiency disease (is_implicated_in)	TET2 IL7R	2.70e-03	42	54	2	DOID:612 (is_implicated_in)
Disease	forced expiratory volume	TET2 CYP3A7 SYNE1 INO80 IL17RD PLEKHM1	3.11e-03	789	54	6	EFO_0004314
Disease	disorder of pharynx	TET2 IL7R	3.23e-03	46	54	2	MONDO_0020592
Disease	response to angiotensin-converting enzyme inhibitor, Cough	FNDC3A ACTR3B	3.23e-03	46	54	2	EFO_0005325, HP_0012735

Protein segments in the cluster

Peptide	Gene	Start	Entry
HYKIPPLGKHYSQRW	TADA3	186	O75528
FNHLKSPHLKYWVPF	BEST3	171	Q8N1M1
KLQEAPRPKSHWDYL	EP400	801	Q96L91
FHSTYRKLPWKDLHP	EPG5	2051	Q9HCE0
KEHLLLYGSIKVPHW	ABCA12	1436	Q86UK0
PEKPSHLHLEKASSW	ARHGEF5	991	Q12774
AIDKPTYATKWPIRH	ACTR3B	66	Q9P1U1
VNKHKPWLEPTYHGI	CLSTN1	31	O94985
PWPLPVYDKHHDAAH	DOT1L	21	Q8TEK3
CKPDHWIHYENLKSP	C7orf31	456	Q8N865
WHSCHKLIYVRPNPK	INTS6	261	Q9UL03
IYHVLWHSEFPKPQI	PARP9	391	Q8IXQ6
ETWSPFHISLKPYHI	INO80	826	Q9ULG1
IAVIWKDPHLHIPMY	OR5H15	46	A6NDH6
IAVIWKDPHLHIPMY	OR5H14	46	A6NHG9
KVMHYALKPVHSPWA	IL17RD	281	Q8NFM7
PHLAWLYRTEDKKSP	MAP10	421	Q9P2G4
LLWRDNKPHHYSEPK	MAPK4	441	P31152
KLDFHWEPLPEHVRK	GALNT15	336	Q8N3T1
LPKPILWHKMHNYFT	ETNK2	191	Q9NVF9
KPFPTHYKDLWDNKH	PARG	496	Q86W56
IVWPSLPDHKKTLEH	IL7R	271	P16871
YLKPSSPKHVRFSWH	CRLF2	116	Q9HC73
YPDKKSLPHVHVALW	POLA1	1146	P09884
IAVIWKDPHLHIPMY	OR5H1	46	A6NKK0
MALIWKDPHLHTPIY	OR5AC1	46	P0C628
ILHWLKHPGDSIYKD	PDP2	186	Q9P2J9
HHWLPYEHPDPKKRC	ADAMTS3	631	O15072
AKQLHLHWSDLPYKG	CA4	111	P22748
PSAKHVLKHPFFWSL	ERN1	821	O75460
IHSHSFKITWDPPKD	FNDC3A	576	Q9Y2H6
VPPKHKETRWKYHFE	GCNT3	256	O95395
SWLVPSPKVYAHHAV	HSDL1	266	Q3SXM5
LHHDPKYWTEPEKFL	CYP3A7	401	P24462
LWPAPGKHSEIYNKL	ENPP6	276	Q6UWR7
KWPSGHPRFRYKEHE	HINFP	371	Q9BQA5
HAVNAPTYKLWHLDP	PTPRK	341	Q15262
KMPLYGLHLWLPKAH	MT-ND4	206	P03905
HLCHYFDEPKLAPWV	RPP40	296	O75818
QPVFWPLLKAVTHKH	PLEKHM1	86	Q9Y4G2
EMLAYPRKPIAHWHS	SYT6	481	Q5T7P8
YPRKPIAHWHSLVEK	SYT9	476	Q86SS6
YIHPHPKDWVGIFKV	TAX1BP1	41	Q86VP1
PWQPDKMLHLVTLYH	SYNE1	4746	Q8NF91
HWIPKMNPTIHKFLY	TDO2	376	P48775
ESKFHHPVRLFWPKS	RIPPLY1	91	Q0D2K3
HSWFRKKHPPAEAPV	STK11	306	Q15831
LTEHYKHHWFPEKPS	BTG2	46	P78543
NGKIYLPYLHEWKHP	TSG101	106	Q99816
SDCPKIHYVIHAPWK	RNASE13	66	Q5GAN3
IHYVIHAPWKAIQKF	RNASE13	71	Q5GAN3
KFKPDVPLHHHAREW	VPS13A	316	Q96RL7
YGKTHSHIPLRPKHW	SPDYE3	471	A6NKU9
KVKDFSWLPHSLSPH	TTC41P	451	Q6P2S7
DHKLKPWLLEVNHSP	TTLL6	351	Q8N841
DPYKWTSHPSHKEVV	VILL	706	O15195
EVNLDSYSKPHHPKW	TMEM81	206	Q6P7N7
VYKRLHKPHHIWKIP	SC5D	146	O75845
TQHYLKPGWIELKAP	TET2	556	Q6N021
RQKHPYSLHWSPREK	ZFTA	146	C9JLR9